Multiple sclerosis drugmakers are in a fix: These days, the U.S. market isn’t delivering the kind of growth that had been fueling big increases in sales.…

Merck & Co.’s U.S. biosimilars are still in the clinic--but the pharma giant wants to prepare the ground for their arrival.

Cancer drug websites load up on numbers about benefits, but tread lightly on side effects, an FDA study found. It’s the latest to flag weaknesses in cancer…

Diabetes powerhouse Sanofi and Verily, its tech partner, are plowing close to $500 million into a joint venture that will take their digital disease-management…

Merck’s Keytruda may have found itself an unexpected ambassador. Rikki Rockett, drummer for the rock band Poison, announced that his oral cancer is gone after…

What do migraines "feel" like? GlaxoSmithKline's latest campaign for Excedrin Migraine will show you.

Everyone in healthcare is trying to figure out wearables, including pharma. Omnicom Health Group is counting on a new digital health partnership to help its…

AstraZeneca now has a one-stop shop for patients. It's a new all-in-one pharma app that offers savings card access, refill reminders and customer care…